Needham Reiterates Buy Rating on Praxis Precision Medicines, Inc. (PRAX)
Rating Change Needham analysts reiterated a Buy rating on Praxis Precision Medicines, Inc. (NASDAQ:PRAX) on June 29, 2026. Market Context Praxis Precision Medicines, Inc.
Read more
